EUVIMEDEUVIMED entdecken
Crossref

Comprehensive solution NMR characterization of bivalirudin, a direct thrombin inhibitor peptide, and its process impurities by heteronuclear spectral fingerprinting at natural isotopic abundance

Subrata H Mishra, Anupreet Kaur, Duyen Vu, Sitaram Bhavaraju

Journal of Pharmaceutical and Biomedical Analysis · 2026

DOI: 10.1016/j.jpba.2026.117684 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2026. Verfasst von Subrata H Mishra und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Standards and Technology, (formerly at US Pharmacopeial Convention, Rockville, MD, USA), Gaithersburg, MD, USA; Institute for B…. Hauptthemen laut MEDLINE: Hirudins, Peptide Fragments, Antithrombins, Drug Contamination. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bivalirudin is a 20-residue synthetic peptide that functions as a bivalent thrombin inhibitor by simultaneously engaging thrombin's active site and exosite I. Despite its widespread clinical use, comprehensive NMR-based characterization of bivalirudin and its process-related impurities has not been reported. Here, we present the first complete heteronuclear NMR analysis of bivalirudin and two major impurities-[Asp9]-bivalirudin (a deamidation-related impurity standard) and [desGlu13]-bivalirudin (a synthesis deletion)-at natural isotopic abundance. Using a combination of 1D and 2D 1H, 13C, and 15N NMR experiments in DMSO-d₆ and aqueous solution, we achieved near-complete backbone and side-chain assignments, now deposited in the BMRB. We demonstrate that 2D heteronuclear amide maps can unambiguously differentiate the parent peptide from its process impurities. Additionally, we report the first solution-state NMR structure of free bivalirudin, revealing a compact architecture wherein the active site- and exosite-binding segments are spatially proximate, potentially reflecting a pre-binding intermediate. This study establishes a practical spectral reference framework and simplified 2D heteronuclear spectral fingerprints for structural integrity assessment and impurity tracking of bivalirudin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HirudinsPeptide FragmentsAntithrombinsDrug ContaminationThrombinNuclear Magnetic Resonance, BiomolecularRecombinant ProteinsMagnetic Resonance Spectroscopy

Stichwörter der Autor:innen

BivalirudinNMRNatural abundancePeptide impuritiesStructure[Asp(9)]-bivalirudin[des-Glu(13)]-bivalirudin

Substanzen

HirudinsbivalirudinPeptide FragmentsRecombinant ProteinsAntithrombinsThrombin

Autor:innen und Institutionen

  • National Institute of Standards and Technology, (formerly at US Pharmacopeial Convention, Rockville, MD, USA), Gaithersburg, MD, USA; Institute for Biosciences and Biotechnology Research, University of Maryland, College…
  • Institute for Biosciences and Biotechnology Research, University of Maryland, College Park, Rockville, MD, USA.
  • US Pharmacopeial Convention, 12601 Twinbrook Parkway, Rockville, MD, USA.

Zitieren

APA

Mishra, S. H., Kaur, A., Vu, D., & Bhavaraju, S. (2026). Comprehensive solution NMR characterization of bivalirudin, a direct thrombin inhibitor peptide, and its process impurities by heteronuclear spectral fingerprinting at natural isotopic abundance. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2026.117684

Vancouver

Mishra SH, Kaur A, Vu D, Bhavaraju S. Comprehensive solution NMR characterization of bivalirudin, a direct thrombin inhibitor peptide, and its process impurities by heteronuclear spectral fingerprinting at natural isotopic abundance. Journal of Pharmaceutical and Biomedical Analysis. 2026. doi:10.1016/j.jpba.2026.117684

BibTeX
@article{Mishra2026,
  author = {Mishra, Subrata H and Kaur, Anupreet and Vu, Duyen and Bhavaraju, Sitaram},
  title = {Comprehensive solution NMR characterization of bivalirudin, a direct thrombin inhibitor peptide, and its process impurities by heteronuclear spectral fingerprinting at natural isotopic abundance},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2026},
  doi = {10.1016/j.jpba.2026.117684}
}
Kostenlos starten →